| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cardiff Oncology, Inc. | Chief Financial Officer | Stock Options | 962K | $2.5M | $2.60 | Mar 7, 2024 | Direct |
| Cardiff Oncology, Inc. | Chief Financial Officer | Common Stock | 67.7K | $339K | $5.00 | Dec 18, 2024 | By Wife |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CRDF | Cardiff Oncology, Inc. | Dec 16, 2024 | 3 | $36.7K | 4 | Dec 18, 2024 | Chief Financial Officer |
| CRDF | Cardiff Oncology, Inc. | Mar 7, 2024 | 1 | $0 | 4 | Mar 7, 2024 | Chief Financial Officer |
| CRDF | Cardiff Oncology, Inc. | Mar 15, 2023 | 1 | $0 | 4 | Mar 16, 2023 | Chief Financial Officer |
| CRDF | Cardiff Oncology, Inc. | Sep 16, 2022 | 1 | $46.7K | 4 | Sep 19, 2022 | Chief Financial Officer |
| CRDF | Cardiff Oncology, Inc. | Mar 9, 2022 | 1 | $0 | 4 | Mar 10, 2022 | Chief Financial Officer |
| CRDF | Cardiff Oncology, Inc. | Sep 10, 2021 | 5 | $194K | 4 | Sep 13, 2021 | Chief Financial Officer |
| CRDF | Cardiff Oncology, Inc. | Jul 12, 2021 | 1 | $0 | 4 | Jul 12, 2021 | Chief Financial Officer |
| CRDF | Cardiff Oncology, Inc. | Jul 12, 2021 | 0 | $0 | 3 | Jul 12, 2021 | Chief Financial Officer |